Bernstein SocGen Group analyst Jeffrey Walch lowered the price target on Nuvalent (NASDAQ: NUVL) to $172.00 (from $189.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE